基于机器学习的儿童霍奇金淋巴瘤和非霍奇金淋巴瘤的生存趋势和结果预测
Yue Zheng1,2, Chunlan Zhang3, Xu Sun3
1Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Clinical and experimental medicine
|June 18, 2024
概括
儿科淋巴瘤的生存率显著提高. 新的预测工具和机器学习模型为患有淋巴瘤的儿童提供了更好的风险评估,优于传统方法.
科学领域:
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
- 生物统计学 生物统计学
背景情况:
- 与成人病例相比,儿科霍奇金淋巴瘤和非霍奇金淋巴瘤存在独特的生物学和管理挑战.
- 在专门为儿科淋巴瘤患者量身定制的生存分析中存在重大差距.
研究的目的:
- 分析1975年至2018年儿科淋巴瘤患者的生存趋势.
- 确定影响儿科淋巴瘤存活率的关键风险因素.
- 开发和验证长期生存和死亡风险的预测工具.
主要方法:
- 分析了来自7,871名儿科和226,211名成年患者 (1975-2018) 淋巴瘤数据.
- 开发一个包含预后因素 (年龄,性别,种族,阶段,亚型,放射治疗) 的预测性名录.
- 利用机器学习模型来预测长期淋巴瘤特异性死亡风险.
主要成果:
- 观察到1年 (19.3%),5年 (41.9%) 和10年 (48.8%) 的儿童淋巴瘤总生存率大幅增加.
- 开发的诺米图表表现出了出色的预测性能 (AUC从0.703到0.776不等),超过了安纳伯分期系统.
- 机器学习模型在预测淋巴瘤特异性死亡时实现了~0.75的AUC,超过了传统方法 (~0.70).
结论:
- 在研究期间,儿童淋巴瘤的生存率明显改善.
- 开发的诺姆图和机器学习模型为预测儿科淋巴瘤的结果提供了可靠的工具.
- 长期监测非淋巴瘤疾病对于儿科淋巴瘤幸存者至关重要.
相关概念视频
01:21Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
01:20Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
01:24Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129